{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Plocabulin",
  "nciThesaurus": {
    "casRegistry": "960210-99-5",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A marine-derived, synthetically produced compound with potential antineoplastic activity. Plocabulin covalently binds to residues lying in the minor groove of DNA, which may result in delayed progression through S phase, cell cycle arrest in the G2/M phase and cell death.",
    "fdaUniiCode": "52Y8L60CR7",
    "identifier": "C95888",
    "preferredName": "Plocabulin",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C2115"
    ],
    "synonyms": [
      "PLOCABULIN",
      "PM-060184",
      "PM060184",
      "Plocabulin"
    ]
  }
}